p53 gene status and modulation of response to cisplatin chemotherapy in non-small cell lung cancer cells

被引：0
|
作者：
Barr, M. P. [1 ,2 ]
Batina, M. B. [1 ,2 ]
Cuffe, S. [1 ,2 ]
Finn, S. [1 ,2 ,3 ]
O'Byrne, K. J. [1 ,2 ,4 ]
机构：
[1] St James Hosp, Thorac Oncol Res Grp, Dublin, Ireland
[2] Univ Dublin Trinity Coll, Dublin 2, Ireland
[3] St James Hosp, Dept Histopathol, Dublin, Ireland
[4] Queensland Univ Technol, Canc & Ageing Res Program, Brisbane, Qld 4001, Australia
来源：
LUNG CANCER | 2014年 / 83卷
关键词：
D O I：
10.1016/S0169-5002(14)70003-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2
引用
收藏
页码：S1 / S1
页数：1
相关论文
共 50 条
  • [1] p53 gene status modulates the chemosensitivity of non-small cell lung cancer cells
    Lai, SL
    Perng, RP
    Hwang, JL
    JOURNAL OF BIOMEDICAL SCIENCE, 2000, 7 (01) : 64 - 70
  • [2] Increased expression levels of p53 correlate with good response to cisplatin-based chemotherapy in non-small cell lung cancer
    Oshita, F
    Nishio, K
    Kameda, Y
    Mitsuda, A
    Ikehara, M
    Tanaka, G
    Yamada, K
    Nomura, I
    Noda, K
    Arai, H
    Ito, H
    Nakayama, H
    ONCOLOGY REPORTS, 2000, 7 (06) : 1225 - 1228
  • [3] p53 Gene status in relation to ex vivo chemosensitivity of non-small cell lung cancer
    U. Vogt
    A. Zaczek
    F. Klinke
    A. Granetzny
    K. Bielawski
    B. Falkiewicz
    Journal of Cancer Research and Clinical Oncology, 2002, 128 : 141 - 147
  • [4] p53 Gene status in relation to ex vivo chemosensitivity of non-small cell lung cancer
    Vogt, U
    Zaczek, A
    Klinke, F
    Granetzny, A
    Bielawski, K
    Falkiewicz, B
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2002, 128 (03) : 141 - 147
  • [5] Increasing P53 Protein Sensitizes Non-Small Cell Lung Cancer to Paclitaxel and Cisplatin In Vitro
    Guntur, Vamsi P.
    Waldrep, J. Clifford
    Guo, Jennifer J.
    Selting, Kim
    Dhand, Rajiv
    ANTICANCER RESEARCH, 2010, 30 (09) : 3557 - 3564
  • [6] p53 mutations in non-small cell lung cancer in Poland
    Niklinski, J
    Rusin, M
    Chyczewski, L
    Sipowicz, M
    Shiao, YE
    Niklinska, WE
    Laudanski, J
    Furman, M
    Chorazy, M
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S30 - S30
  • [7] P53 as a prognostic indicator in non-small cell lung cancer
    Tsobanidou, Ch.
    Papageorgiou, A.
    Anestakis, D.
    Paraskevopoulos, P.
    Angel, J.
    Toliou, Th.
    LUNG CANCER, 2006, 52 : S39 - S39
  • [8] The p53 Target Gene SIVA Enables Non-Small Cell Lung Cancer Development
    Van Nostrand, Jeanine L.
    Brisac, Alice
    Mello, Stephano S.
    Jacobs, Suzanne B. R.
    Luong, Richard
    Attardi, Laura D.
    CANCER DISCOVERY, 2015, 5 (06) : 622 - 635
  • [9] FHIT and p53 status and response to platinum-based treatment in advanced non-small cell lung cancer
    Cortinovis, D. L.
    Andriani, F.
    Livio, A.
    Fabbri, A.
    Perrone, F.
    Marcomini, B.
    Pilotti, S.
    Mariani, L.
    Bidoli, P.
    Bajetta, E.
    Roz, L.
    Sozzi, G.
    CURRENT CANCER DRUG TARGETS, 2008, 8 (05) : 342 - 348
  • [10] The p53 codon 72 Proline allele is associated with p53 gene mutations in non-small cell lung cancer
    Hu, YC
    McDermott, MP
    Ahrendt, SA
    CLINICAL CANCER RESEARCH, 2005, 11 (07) : 2502 - 2509
12345